Last year, there was a significant increase and requirement trend for cyber security or resilient manufacturing consultancy work. According to a Deloitte report, the pharma sector is the primary target for cyber-criminals looking to steal intellectual property (IP).
Pharma is adopting such practices as robust cyber security maintenance processes (ensuring the highest level of protection at all times), cyber hygiene standard practices (to prevent compromise of operational technology [OT] networks) and control systems security responses.
There has been a rising need in biopharma for increased flexibility with simplified production strategies. One area of growth has been the adoption of single use technology. Single use or disposable bioprocessing equipment is now used widely throughout pre-clinical and clinical manufacturing and is increasingly being adopted for commercial product manufacturing.
Read more here.